Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Retatrutide for Sale > 2026 latest Retatrutide peptide powder 10mg 20mg in stock
2026 latest Retatrutide peptide powder 10mg 20mg in stock buy - large image1
2026 latest Retatrutide peptide powder 10mg 20mg in stock buy - image1
2026 latest Retatrutide peptide powder 10mg 20mg in stock buy - image2
2026 latest Retatrutide peptide powder 10mg 20mg in stock buy - image3
2026 latest Retatrutide peptide powder 10mg 20mg in stock buy - image4
2026 latest Retatrutide peptide powder 10mg 20mg in stock buy - image5
2026 latest Retatrutide peptide powder 10mg 20mg in stock buy - image6

2026 latest Retatrutide peptide powder 10mg 20mg in stock

6828 Inquiries

Unit Price: Get Latest Price
CAS No.:

2381089-83-2

Grade:

Industrial Grade

Content:

99.9%

Port:

china

Brand:

KZY

Packaging:

10 vials/box

Price valid (until):

2026-08-22

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Retatrutide,Tirzepatide,Samaglutide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    More and more people are choosing to use peptide products for weight loss and weight management. We welcome more people to learn about and use peptide products. If you would like to learn more about this product, please feel free to contact us at any time. We are committed to providing excellent customer service and assisting our clients in achieving their business goals.

    Shop 2026 latest Retatrutide peptide powder 10mg 20mg in stock-Detailed Image 1

    Shop 2026 latest Retatrutide peptide powder 10mg 20mg in stock-Detailed Image 2

    Items Specifications
    Retatrutide 5mg/10mg/15mg/20mg/30mg/60mg*10 vials
    Appearance White to off‑white lyophilized powder
    MOQ 1 Box
    Shipping Method DHL,UPS, Special Line,USPS...
    Shelf Life 24 months under proper storage
    COA Available


    Shipping


    We collaborate with numerous leading logistics companies worldwide. Our global transportation network guarantees that our safe and efficient logistics services can meet your urgent needs.

    Shop 2026 latest Retatrutide peptide powder 10mg 20mg in stock-Detailed Image 3


      Customer review


    We offer a variety of peptide products, providing our customers with high-quality and competitively priced peptide products.
    Customers who have ordered our products have all given very positive feedback.

    Shop 2026 latest Retatrutide peptide powder 10mg 20mg in stock-Detailed Image 4


    Factory


    We have standardized dust-free clean workshops with standardized whole-process operations. We strictly control the production environment and process details to steadily deliver high-quality products.

    Shop 2026 latest Retatrutide peptide powder 10mg 20mg in stock-Detailed Image 5


    FAQ 


    1.How to make an order?
    Send me message and let me know what you need with quantity , then I will calculate to you.

    2.Can we do printing or label on the bottles?
    Yes, can. We can offer various printing ways,such, screen printing, hot stamping, label printing.

    3.What is the normal lead time?
    For stock products, within 24-48 hours after we receive your payment. For smaller customize color bottles, we will ship out within 3-15 days.

    4.What is your shipping terms?
    Faster ways: EDEX, DHL, UPS, TNT, etc by sea or by Shipping conomy

    5.Why did you choose us?
    We are a professional peptide supplier, offering four key advantages: high-purity products, efficient and safe global logistics, flexible and convenient payment methods, and a professional and dedicated team - all of which are designed to help your business reach a higher level.


      Contact


    Whatsapp :+44 7865082564
    Email: Luna@cn-kzy.com

    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    Molecular Formula:

    C221H342N46O68

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    4731.33

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Retatrutide,Tirzepatide,Samaglutide

    Location:

    Room 205, Sanyuanli Avenue, Baiyun District, Guangzhou City

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    1

    Total Annual Revenue:

    $10 million-$25 million

    Total Employees:

    101-200

    Year of Establishment:

    2026

  • Inquiry History
    6828 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    Tirzepatide 99.9% Liquid 2381089-83-2 TeruiOP

    1 MT Sep 6, 2023
    United States

    Retatrutide/LY3437943/GIPR/GLP-1R 98% Powder 2381089-83-2 Senwayer

    1 G Sep 3, 2023
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.